-
Pesticide Exposure and Parkinson’s Disease Motor Subtype
-
PET and Clinical Evidence for Neuroprotective Effects of KM-819 on MSA
-
Pharmacokinetic Analysis of Subcutaneous Levodopa/Carbidopa Delivery With ND0612
-
Pharmacological PGC-1α Activation Mitigates Dopaminergic Degeneration in Parkinson’s Disease Via Regulating Mitochondrial Homeostasis
-
Phase 1 and 1b Pharmacodynamic Data Support Central Modulation of Lysosomal Pathways With BIIB122/DNL151, a LRRK2 Kinase Inhibitor: Insights for the LUMA Trial
-
Phase I randomized, double-blind study to evaluate feasibility, safety, and clinical responses of implanting autologous peripheral nerve tissue into the nucleus basalis of Meynert or substantia nigra for non-motor or motor symptoms in patients with Parkinson’s disease undergoing DBS surgery (STAR) Trial
-
Phenotypic Overlap of CACNA1A-Related Disorders
-
Phenotypic spectrum and response to deep brain stimulation (DBS) in patients with dystonia due to variants in the KMT2B gene: A description of six Chilean cases
-
Phenotypic Spectrum In Children And Adolescents With Glucose Transporter 1 Deficiency A Multicentric Retrospective Study
-
Phenotypic Spectrum of Movement Disorders in TBC1D24 Gene Variants: A Case Series
- « Previous Page
- 1
- …
- 124
- 125
- 126
- 127
- 128
- …
- 181
- Next Page »